Deferred Tax Assets, Gross of HERON THERAPEUTICS, INC. /DE/ from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • HERON THERAPEUTICS, INC. /DE/ Deferred Tax Assets, Gross for the quarter ending 31 Dec 2025 was $414,999,000, a 1.1% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $414,999,000 -$4,808,000 -1.1% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $419,807,000 -$11,319,000 -2.6% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $431,126,000 +$6,408,000 +1.5% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $424,718,000 +$44,881,000 +12% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q4 2021 $379,837,000 +$49,865,000 +15% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q4 2020 $329,972,000 +$54,248,000 +20% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q4 2019 $275,724,000 +$52,865,000 +24% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q4 2018 $222,859,000 +$50,728,000 +29% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q4 2017 $172,131,000 +$3,241,000 +1.9% 31 Dec 2017 10-K 22 Feb 2019 2018 FY
Q4 2016 $168,890,000 +$55,173,000 +49% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q4 2015 $113,717,000 +$40,445,000 +55% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q4 2014 $73,272,000 +$32,035,000 +78% 31 Dec 2014 10-K 19 Feb 2016 2015 FY
Q4 2013 $41,237,000 +$22,037,000 +115% 31 Dec 2013 10-K 13 Mar 2015 2014 FY
Q4 2012 $19,200,000 +$8,900,000 +86% 31 Dec 2012 10-K 07 Mar 2014 2013 FY
Q4 2011 $10,300,000 31 Dec 2011 10-K 07 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.